Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Health care reform and the need for comparative-effectiveness research.

Mushlin AI, Ghomrawi H.

N Engl J Med. 2010 Jan 21;362(3):e6. doi: 10.1056/NEJMp0912651. Epub 2010 Jan 6. No abstract available.

2.

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.

Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK.

Ann Intern Med. 2010 Jan 5;152(1):1-9. doi: 10.7326/0003-4819-152-1-201001050-00179. Epub 2009 Nov 30.

PMID:
19949136
3.

Withdrawal of statins and risk of subarachnoid hemorrhage.

Risselada R, Straatman H, van Kooten F, Dippel DW, van der Lugt A, Niessen WJ, Firouzian A, Herings RM, Sturkenboom MC.

Stroke. 2009 Aug;40(8):2887-92. doi: 10.1161/STROKEAHA.109.552760. Epub 2009 Jun 11.

4.

Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal.

Sposito AC, Carvalho LS, Cintra RM, Araújo AL, Ono AH, Andrade JM, Coelho OR, Quinaglia e Silva JC; Brasilia Heart Study Group.

Atherosclerosis. 2009 Nov;207(1):191-4. doi: 10.1016/j.atherosclerosis.2009.04.008. Epub 2009 Apr 17.

PMID:
19464010
5.

Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.

Lordkipanidzé M, Diodati JG, Pharand C.

Pharmacol Ther. 2009 Aug;123(2):178-86. doi: 10.1016/j.pharmthera.2009.03.019. Epub 2009 May 6. Review.

PMID:
19426760
6.

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M.

BMJ. 2008 May 17;336(7653):1114-7. doi: 10.1136/bmj.39553.670231.25. Epub 2008 May 14.

7.

Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase.

Chen H, Ren JY, Xing Y, Zhang WL, Liu X, Wu P, Wang RJ, Luo Y.

Int J Cardiol. 2009 Jan 24;131(3):313-20. doi: 10.1016/j.ijcard.2007.10.044. Epub 2008 Jan 24.

PMID:
18221806
8.
9.

Statin treatment withdrawal in ischemic stroke: a controlled randomized study.

Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J.

Neurology. 2007 Aug 28;69(9):904-10.

PMID:
17724294
10.

Effect of statin withdrawal on frequency of cardiac events after vascular surgery.

Schouten O, Hoeks SE, Welten GM, Davignon J, Kastelein JJ, Vidakovic R, Feringa HH, Dunkelgrun M, van Domburg RT, Bax JJ, Poldermans D.

Am J Cardiol. 2007 Jul 15;100(2):316-20. Epub 2007 May 22.

PMID:
17631090
11.

Statin withdrawal: clinical implications and molecular mechanisms.

Cubeddu LX, Seamon MJ.

Pharmacotherapy. 2006 Sep;26(9):1288-96. Review.

PMID:
16945051
12.

Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.

Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ; National Registry of Myocardial Infarction 4 Investigators.

Am J Cardiol. 2005 Sep 1;96(5):611-6.

PMID:
16125480
13.

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.

Am J Med. 2004 Jul 15;117(2):73-81.

PMID:
15234641
14.

Antiplatelet drug discontinuation is a risk factor for ischemic stroke.

Sibon I, Orgogozo JM.

Neurology. 2004 Apr 13;62(7):1187-9.

PMID:
15079022
16.

Endocrine withdrawal syndromes.

Hochberg Z, Pacak K, Chrousos GP.

Endocr Rev. 2003 Aug;24(4):523-38. Review.

PMID:
12920153
17.

Withdrawal of statins in patients with acute coronary syndromes.

Heeschen C, Hamm CW, Laufs U, Böhm M, Snapinn S, White HD.

Circulation. 2003 Jan 28;107(3):e27. No abstract available.

18.

Withdrawal of statins increases event rates in patients with acute coronary syndromes.

Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.

Circulation. 2002 Mar 26;105(12):1446-52.

19.

Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ.

J Am Coll Cardiol. 2002 Mar 6;39(5):811-7.

20.

Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men.

Laufs U, Wassmann S, Hilgers S, Ribaudo N, Böhm M, Nickenig G.

Am J Cardiol. 2001 Dec 1;88(11):1306-7. No abstract available.

PMID:
11728362

Supplemental Content

Support Center